The alpha-globin gene cluster at chromosome band 16p13 consists of two adjacent alpha-globin genes (HBA1 and HBA2) on each chromosome for a total of four genes. This assay detects the six most common deletions found in individuals with alpha thalassemia (alpha-3.7, alpha-4.2, SEA [Southeast Asian], FIL [Filipino], THAI [Thailand], and MED [Mediterranean]). Approximately 95% of all alpha-thalassemia is due to deletions detectable by this test (detection rates may vary by ethnicity).
Genetics & Solid Tumor Clinical Request Form
In most instances, this is performed as a first-tier test when evaluating for alpha thalassemia. If testing for alpha-globin sequencing is indicated, order “Alpha Hemoglobin DNA Sequence”. To order testing for a relative of an individual with a known alpha-globin sequence variant, order “Alpha Hemoglobin Sequencing, Relative”.
Indications for Testing
NOTE: For outside patients please provide additional clinical and family history. Please include the following available laboratory data: CBC, Hb electrophoresis, and iron studies
Code | Name |
---|---|
AGRES | Alpha Globin Result |
AGINF | Alpha Globin Clinical Information |
AGINT | Alpha Globin Interpretation |
AGMET | Alpha Globin Methods |
AGDI | Alpha Globin Director |
This assay detects the six most common deletions found in individuals with alpha thalassemia (alpha-3.7, alpha-4.2, SEA [Southeast Asian], FIL [Filipino], THAI [Thailand], and MED [Mediterranean]). These target deletions on the HBA1 and HBA2 genes are evaluated using PCR (Polymerase Chain Reaction) with agarose gel electrophoresis. Other variants in the HBA1 and HBA2 genes (e.g., hemoglobin Constant Spring, alpha-thalassemia Saudi) are not detectable by this assay.
This test was developed and its performance characteristics were determined by the University of Washington Department of Laboratory Medicine and Pathology. It has not been cleared or approved by the US Food and Drug Administration. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical laboratory testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.
Negative/No alpha globin gene deletion detected.
Acceptable:
Unacceptable: Heparin green top tubes, buccal swab
SPS specimen handling:
If fetal tissue (cultured amniocytes or chorionic villi) was received for prenatal testing, consultation with the laboratory is required. Please notify the Genetics lab about prenatal studies via email at geneticshelp@uw.edu or call 206-598-7021.
For clients outside of UW, please include the most recent CBC and Hb electrophoresis result/s (if available), and/or any relevant clinical history.
UW-MT |
Genetics
Attention: Genetics Lab Tel: 206-598–6429 M–F (7:30 AM–4:00 PM) Tel (EXOME only): 206-543-0459 |
Faculty |
---|